Latest news
2022-01-18
Realheart provides clarification on UAE media reports
2022-01-18
Azad Najar a speaker at the ICPM conference today
2021-12-21
Realheart receives SEK 200,000 funding from Vinnova
The share
Realheart is a public company listed on Nasdaq First North Growth Market since December 17 2021, under the name (HEART).
RIGHT NOW
Congestive heart failure is a public health issue affecting 64 million people worldwide.
Watch “Living on borrowed time” which tells the story of heart failure patient Gustav – and of Realheart’s determination to create an artificial heart to save his life.
Realheart TAH
The Swedish innovation tradition has provided the world with medical technological inventions such as the heart and lung machine, the pacemaker and the dialysis machine. The next great innovation is Realheart’s artificial heart, Realheart TAH, a Swedish invention that not only saves lives but also creates a better quality of a prolonged life.
